Hypermethylation and down-regulation of Slit3 has been reported in several types of cancers such as thyroid cancer, colorectal cancer, gastric cancer, nasopharyngeal carcinoma, cervical cancer, ovarian cancer and pancreatic ductal adenocarcinoma [23–32]. Here, SLIT3 is linked to thyroid cancer.